Effects of 5-FU and heparin-based portal infusion chemotherapy combined with MMC and CDDP after curative resection of pancreatic cancer.
Not Applicable
Recruiting
- Conditions
- patients after the resection of pancreatic cancer
- Registration Number
- JPRN-UMIN000002976
- Lead Sponsor
- Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
Not provided
Exclusion Criteria
inoperable cases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method overall survival
- Secondary Outcome Measures
Name Time Method